TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ORGO

Organogenesis Holdings Inc

Healthcare · Drug Manufacturers - Specialty & Generic

1.40$ -1.4% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement ORGO
Line item 2001 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
+9,407.7% -100.0% +34.9% +29.6% +38.2% -3.5% -3.9% +11.3% +16.8%
+3,789.8% -99.6% +2,100.2% +1,398.5% +10.4% +15.0% +30.8% -8.0% +1.4% +8.7% +18.8%
-100.4% +48.5% +35.6% +40.7% -2.1% -5.6% +12.1% +16.2%
+146.0% +61.7% +44.4% +18.5% +37.8% +35.7% +53.1% +29.3% +11.6% +13.3% -11.4%
-97.0% +729.5% +2,100.2% +3,427.2% +22.6% +1.1% +21.9% +14.0% -5.2% +9.9% +12.2%
+3,358.2% -99.8% +97,648.9% -15.3% +24.4% +4.4% +25.3% +15.2% -2.9% +17.0% +0.6%
-2,300.2% +170.5% -69.1% -43.8% -110.2%
-55.6% +334.5% -17.1% +25.4% -35.8% -72.2% +9.0% -29.5% +47.7%
+255.1% -67.9% -48.8% -127.0%
+78.6% +253.3% -5,970.9% +14.7% -167.3%
+446.6% -83.5% -68.2% -82.6% +4,201.0%
-164.6% +133.7% -53.7% -10.6% -56.3% +368.9%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?